 <h1>Depade Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>naltrexone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about naltrexone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Depade.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to naltrexone: oral tablet</i></p><p>Other dosage forms:</p><ul><li>intramuscular powder for suspension extended release</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, naltrexone (the active ingredient contained in Depade) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking naltrexone:</p><p>
<i>Less common</i>
</p><ul>
<li>Skin rash</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach pain (severe)</li>
<li>blurred vision, aching, burning, or swollen eyes</li>
<li>chest pain</li>
<li>confusion</li>
<li>discomfort while urinating or frequent urination</li>
<li>fever</li>
<li>hallucinations or seeing, hearing, or feeling things that are not there</li>
<li>itching</li>
<li>mental depression or other mood or mental changes</li>
<li>ringing or buzzing in the ears</li>
<li>shortness of breath</li>
<li>swelling of the face, feet, or lower legs</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of naltrexone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach cramping or pain (mild or moderate)</li>
<li>anxiety, nervousness, restlessness or trouble sleeping</li>
<li>headache</li>
<li>joint or muscle pain</li>
<li>nausea or vomiting</li>
<li>unusual tiredness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>constipation</li>
<li>cough, hoarseness, runny or stuffy nose, sinus problems, sneezing, or sore throat</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>fast or pounding heartbeat</li>
<li>increased thirst</li>
<li>irritability</li>
<li>loss of appetite</li>
<li>sexual problems in males</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to naltrexone: compounding powder, intramuscular powder for injection extended release, oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (25%), dizziness/syncope (13%)</p>
<p><b>Common</b> (1% to 10%): Somnolence/sedation</p>
<p><b>Frequency not reported</b>: Lethargy, cerebral arterial aneurysm, convulsions, disturbance in attention, dysgeusia, mental impairment, migraine, ischemic stroke, paresthesia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia/sleep disorder (14%), anxiety (12%)</p>
<p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Suicide attempt/ideation</p>
<p><b>Frequency not reported</b>: Irritability, abnormal dreams, agitation, alcohol withdrawal syndrome, euphoric mood, delirium, libido decreased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (33%), vomiting NOS (14%), diarrhea (13%), abdominal pain (11%)</p>
<p><b>Common</b> (1% to 10%): Dry mouth, toothache</p>
<p><b>Frequency not reported</b>: Abdominal discomfort, colitis, constipation, flatulence, gastroesophageal reflux disease, gastrointestinal hemorrhage, hemorrhoids, pancreatitis acute, paralytic ileus<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Alanine aminotransferase increased (13%), aspartate aminotransferase increased (10%)</p>
<p><b>Common</b> (1% to 10%): Gamma-glutamyltransferase increased</p>
<p><b>Frequency not reported</b>: Lymphadenopathy including cervical adenitis, white blood cell count increased, cholecystitis acute, cholelithiasis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site tenderness (45%), injection site induration (35%), injection site pain (17%), other injection site reaction (primarily nodules, swelling) (15%), injection site pruritus (10%)</p>
<p><b>Common</b> (1% to 10%): Injection site ecchymosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/arthritis/joint stiffness (12%)</p>
<p><b>Common</b> (1% to 10%): Back pain/stiffness, muscle cramps</p>
<p><b>Frequency not reported</b>: Chills, joint stiffness, muscle spasms, myalgia, pain in limb<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenic conditions (23%)</p>
<p><b>Frequency not reported</b>: Chest pain, chest tightness, abortion missed<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Angina pectoris, angina unstable, atrial fibrillation, cardiac failure congestive, coronary artery atherosclerosis, myocardial infarction, palpitations, deep vein thrombosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Chronic obstructive pulmonary disease, dyspnea, pharyngolaryngeal pain, sinus congestion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Face edema, night sweats, pruritus, sweating increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia/appetite decreased NOS/appetite disorder NOS (14%)</p>
<p><b>Frequency not reported</b>: Weight decreased, weight increased, appetite increased, dehydration<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Abnormal creatinine phosphokinase levels (17%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Eosinophil counts increased, decreased platelet count<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Conjunctivitis, vision blurred<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reaction (including angioneurotic edema and urticaria)</p>
<p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Pharyngitis (11%)</p>
<p><b>Common</b> (1% to 10%): Nasopharyngitis</p>
<p><b>Frequency not reported</b>: Seasonal allergies<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Vivitrol (naltrexone)." Alkermes, Inc, Cambridge, MA. </p><p id="ref_2">2. "Product Information. Naltrexone Hydrochloride (naltrexone)." Accord Biopharma Inc, Durham, NC. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What happens if you drink alcohol while taking naltrexone?</li>
<li>Can you drink alcohol on Vivitrol or will you get sick?</li>
<li>Should I take naltrexone in the morning or at night?</li>
<li>How long does Vivitrol last in your system?</li>
<li>What to avoid when taking naltrexone?</li>
<li>How long does naltrexone take to work?</li>
<li>What happens if you take opiates while on Vivitrol?</li>
<li>What's the difference between naltrexone and naloxone?</li>
<li>Is naltrexone a controlled substance?</li>
<li>Does this drug make you sleepy?</li>
<li>Does this drug block endorphins?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Depade (naltrexone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Drug class: antidotes</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Vivitrol, Revia</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Alcohol Dependence</li>
<li>Opiate Dependence</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to naltrexone: compounding powder, intramuscular powder for injection extended release, oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (25%), dizziness/syncope (13%)</p><p><b>Common</b> (1% to 10%): Somnolence/sedation</p><p><b>Frequency not reported</b>: Lethargy, cerebral arterial aneurysm, convulsions, disturbance in attention, dysgeusia, mental impairment, migraine, ischemic stroke, paresthesia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia/sleep disorder (14%), anxiety (12%)</p><p><b>Common</b> (1% to 10%): Depression</p><p><b>Uncommon</b> (0.1% to 1%): Suicide attempt/ideation</p><p><b>Frequency not reported</b>: Irritability, abnormal dreams, agitation, alcohol withdrawal syndrome, euphoric mood, delirium, libido decreased<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (33%), vomiting NOS (14%), diarrhea (13%), abdominal pain (11%)</p><p><b>Common</b> (1% to 10%): Dry mouth, toothache</p><p><b>Frequency not reported</b>: Abdominal discomfort, colitis, constipation, flatulence, gastroesophageal reflux disease, gastrointestinal hemorrhage, hemorrhoids, pancreatitis acute, paralytic ileus<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Alanine aminotransferase increased (13%), aspartate aminotransferase increased (10%)</p><p><b>Common</b> (1% to 10%): Gamma-glutamyltransferase increased</p><p><b>Frequency not reported</b>: Lymphadenopathy including cervical adenitis, white blood cell count increased, cholecystitis acute, cholelithiasis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site tenderness (45%), injection site induration (35%), injection site pain (17%), other injection site reaction (primarily nodules, swelling) (15%), injection site pruritus (10%)</p><p><b>Common</b> (1% to 10%): Injection site ecchymosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/arthritis/joint stiffness (12%)</p><p><b>Common</b> (1% to 10%): Back pain/stiffness, muscle cramps</p><p><b>Frequency not reported</b>: Chills, joint stiffness, muscle spasms, myalgia, pain in limb<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenic conditions (23%)</p><p><b>Frequency not reported</b>: Chest pain, chest tightness, abortion missed<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Angina pectoris, angina unstable, atrial fibrillation, cardiac failure congestive, coronary artery atherosclerosis, myocardial infarction, palpitations, deep vein thrombosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Chronic obstructive pulmonary disease, dyspnea, pharyngolaryngeal pain, sinus congestion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Face edema, night sweats, pruritus, sweating increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia/appetite decreased NOS/appetite disorder NOS (14%)</p><p><b>Frequency not reported</b>: Weight decreased, weight increased, appetite increased, dehydration<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Abnormal creatinine phosphokinase levels (17%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Eosinophil counts increased, decreased platelet count<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Conjunctivitis, vision blurred<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reaction (including angioneurotic edema and urticaria)</p><p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Pharyngitis (11%)</p><p><b>Common</b> (1% to 10%): Nasopharyngitis</p><p><b>Frequency not reported</b>: Seasonal allergies<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Vivitrol (naltrexone)." Alkermes, Inc, Cambridge, MA. </p><p id="ref_2">2. "Product Information. Naltrexone Hydrochloride (naltrexone)." Accord Biopharma Inc, Durham, NC. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What happens if you drink alcohol while taking naltrexone?</li>
<li>Can you drink alcohol on Vivitrol or will you get sick?</li>
<li>Should I take naltrexone in the morning or at night?</li>
<li>How long does Vivitrol last in your system?</li>
<li>What to avoid when taking naltrexone?</li>
<li>How long does naltrexone take to work?</li>
<li>What happens if you take opiates while on Vivitrol?</li>
<li>What's the difference between naltrexone and naloxone?</li>
<li>Is naltrexone a controlled substance?</li>
<li>Does this drug make you sleepy?</li>
<li>Does this drug block endorphins?</li>
</ul><h2>More about Depade (naltrexone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Drug class: antidotes</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Alcohol Dependence</li>
<li>Opiate Dependence</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>